Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2026-04-22 @ 2:54 AM
Study NCT ID:
NCT05239533
Status:
RECRUITING
Last Update Posted:
2025-05-18
First Post:
2022-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
21-328
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None